Simplicity Wealth »

Fate Therapeutics shares owned by Simplicity Wealth

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Simplicity Wealth from 13F filings

Historical chart of Simplicity Wealth investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by Simplicity Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by Simplicity Wealth

Quarter filed Position value Share count Share price at filing
2024-03-31 $81k 11k 7.34

More positions owned by Simplicity Wealth

Vanguard Index Fds Large Cap Etf (VV)
Sprott Physical Gold & Silve Tr Unit (CEF)
Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Mid Cap Etf (VO)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Sprott Physical Gold Tr Unit (PHYS)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
NVIDIA Corporation (NVDA)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Amazon (AMZN)

View all positions for Simplicity Wealth

Top funds holding Fate Therapeutics

Redmile Group
Vanguard Group
BlackRock
Boxer Capital
Bellevue Group
Johnson & Johnson
Citadel Advisors
Morgan Stanley
D. E. Shaw & Co
Suvretta Capital Management
Assenagon Asset Management
Holocene Advisors
Deerfield Management Company
Adage Capital Partners GP
Goldman Sachs Group

View all funds holding Fate Therapeutics